Is GDR or ABDX more profitable?

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Abingdon Health -33.88% -55.91% -17.93%

Is GDR or YGEN more profitable?

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Yourgene Health -27.55% -27.06% -6.71%

Which has stronger earnings and valuation, VRCI or GDR?

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Verici Dx £3.66M 2.04 -£6.56M -£0.90 N/A genedrive £929K 19.88 -£21.22M -£0.79 N/A

Is VRCI or GDR more profitable?

Verici Dx has a net margin of -193.05% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -138.93% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets Verici Dx -193.05% -138.93% -26.14% genedrive -500.75% -1,044.57% -74.09%

Which has preferable valuation & earnings, GDR or AGL?

genedrive has higher earnings, but lower revenue than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio genedrive £929K 19.88 -£21.22M -£0.79 N/A ANGLE £2.62M 2.89 -£21.76M -£4.80 N/A

Is GDR or AGL more profitable?

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -1,444.04%. ANGLE's return on equity of -191.36% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% ANGLE -1,444.04% -191.36% -29.89%

Is GDR or PRM more profitable?

Proteome Sciences has a net margin of -81.50% compared to genedrive's net margin of -500.75%. Proteome Sciences' return on equity of 33.80% beat genedrive's return on equity. Company Net Margins Return on Equity Return on Assets genedrive -500.75% -1,044.57% -74.09% Proteome Sciences -81.50% 33.80% -19.25%

genedrive (GDR) Competitors

GBX 1.15 0.00 (0.00%)

As of 11:25 AM Eastern

Compare

GDR vs. ABDX, YGEN, VRCI, AGL, and PRM

Should you buy genedrive stock or one of its competitors? MarketBeat compares genedrive with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with genedrive include Abingdon Health (ABDX), Yourgene Health (YGEN), Verici Dx (VRCI), ANGLE (AGL), and Proteome Sciences (PRM).

How does genedrive compare to Abingdon Health?

genedrive (LON:GDR) and Abingdon Health (LON:ABDX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

In the previous week, genedrive had 3 more articles in the media than Abingdon Health. MarketBeat recorded 3 mentions for genedrive and 0 mentions for Abingdon Health. Abingdon Health's average media sentiment score of 0.76 beat genedrive's score of 0.37 indicating that Abingdon Health is being referred to more favorably in the news media.

Company	Overall Sentiment
genedrive	Neutral
Abingdon Health	Positive

Abingdon Health has a net margin of -33.88% compared to genedrive's net margin of -500.75%. Abingdon Health's return on equity of -55.91% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Abingdon Health	-33.88%	-55.91%	-17.93%

genedrive has a beta of 0.989, suggesting that its stock price is 1% less volatile than the broader market. Comparatively, Abingdon Health has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market.

0.1% of genedrive shares are owned by institutional investors. Comparatively, 3.7% of Abingdon Health shares are owned by institutional investors. 29.0% of genedrive shares are owned by insiders. Comparatively, 8.0% of Abingdon Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Abingdon Health has higher revenue and earnings than genedrive. Abingdon Health is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	19.88	-£21.22M	-£0.79	N/A
Abingdon Health	£9.57M	2.83	-£796.37K	-£0.81	N/A

Summary

Abingdon Health beats genedrive on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to Yourgene Health?

genedrive (LON:GDR) and Yourgene Health (LON:YGEN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.

In the previous week, genedrive had 3 more articles in the media than Yourgene Health. MarketBeat recorded 3 mentions for genedrive and 0 mentions for Yourgene Health. genedrive's average media sentiment score of 0.37 beat Yourgene Health's score of 0.00 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Neutral
Yourgene Health	Neutral

0.1% of genedrive shares are held by institutional investors. Comparatively, 23.3% of Yourgene Health shares are held by institutional investors. 29.0% of genedrive shares are held by company insiders. Comparatively, 64.4% of Yourgene Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Yourgene Health has a net margin of -27.55% compared to genedrive's net margin of -500.75%. Yourgene Health's return on equity of -27.06% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Yourgene Health	-27.55%	-27.06%	-6.71%

genedrive has a beta of 0.989, indicating that its share price is 1% less volatile than the broader market. Comparatively, Yourgene Health has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Yourgene Health has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Yourgene Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	19.88	-£21.22M	-£0.79	N/A
Yourgene Health	£29.67M	0.00	-£8.17M	-£0.01	N/A

Summary

Yourgene Health beats genedrive on 8 of the 12 factors compared between the two stocks.

How does genedrive compare to Verici Dx?

Verici Dx (LON:VRCI) and genedrive (LON:GDR) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

7.9% of Verici Dx shares are held by institutional investors. Comparatively, 0.1% of genedrive shares are held by institutional investors. 1.3% of Verici Dx shares are held by company insiders. Comparatively, 29.0% of genedrive shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Verici Dx has a net margin of -193.05% compared to genedrive's net margin of -500.75%. Verici Dx's return on equity of -138.93% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verici Dx	-193.05%	-138.93%	-26.14%
genedrive	-500.75%	-1,044.57%	-74.09%

Verici Dx has higher revenue and earnings than genedrive. genedrive is trading at a lower price-to-earnings ratio than Verici Dx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verici Dx	£3.66M	2.04	-£6.56M	-£0.90	N/A
genedrive	£929K	19.88	-£21.22M	-£0.79	N/A

In the previous week, genedrive had 3 more articles in the media than Verici Dx. MarketBeat recorded 3 mentions for genedrive and 0 mentions for Verici Dx. genedrive's average media sentiment score of 0.37 beat Verici Dx's score of 0.00 indicating that genedrive is being referred to more favorably in the news media.

Company	Overall Sentiment
Verici Dx	Neutral
genedrive	Neutral

Verici Dx has a beta of 1.256, indicating that its share price is 26% more volatile than the broader market. Comparatively, genedrive has a beta of 0.989, indicating that its share price is 1% less volatile than the broader market.

Summary

Verici Dx beats genedrive on 8 of the 13 factors compared between the two stocks.

How does genedrive compare to ANGLE?

genedrive (LON:GDR) and ANGLE (LON:AGL) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

In the previous week, genedrive had 3 more articles in the media than ANGLE. MarketBeat recorded 3 mentions for genedrive and 0 mentions for ANGLE. ANGLE's average media sentiment score of 0.76 beat genedrive's score of 0.37 indicating that ANGLE is being referred to more favorably in the news media.

Company	Overall Sentiment
genedrive	Neutral
ANGLE	Positive

0.1% of genedrive shares are owned by institutional investors. Comparatively, 17.5% of ANGLE shares are owned by institutional investors. 29.0% of genedrive shares are owned by insiders. Comparatively, 2.7% of ANGLE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

genedrive has higher earnings, but lower revenue than ANGLE. genedrive is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	19.88	-£21.22M	-£0.79	N/A
ANGLE	£2.62M	2.89	-£21.76M	-£4.80	N/A

genedrive has a beta of 0.989, indicating that its share price is 1% less volatile than the broader market. Comparatively, ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market.

genedrive has a net margin of -500.75% compared to ANGLE's net margin of -1,444.04%. ANGLE's return on equity of -191.36% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
ANGLE	-1,444.04%	-191.36%	-29.89%

Summary

genedrive beats ANGLE on 7 of the 13 factors compared between the two stocks.

How does genedrive compare to Proteome Sciences?

genedrive (LON:GDR) and Proteome Sciences (LON:PRM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

genedrive has a beta of 0.989, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Proteome Sciences has a beta of 0.148, meaning that its stock price is 85% less volatile than the broader market.

Proteome Sciences has higher revenue and earnings than genedrive. Proteome Sciences is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
genedrive	£929K	19.88	-£21.22M	-£0.79	N/A
Proteome Sciences	£3.76M	1.49	-£4.08M	-£1.04	N/A

In the previous week, genedrive had 3 more articles in the media than Proteome Sciences. MarketBeat recorded 3 mentions for genedrive and 0 mentions for Proteome Sciences. genedrive's average media sentiment score of 0.37 beat Proteome Sciences' score of 0.00 indicating that genedrive is being referred to more favorably in the media.

Company	Overall Sentiment
genedrive	Neutral
Proteome Sciences	Neutral

0.1% of genedrive shares are held by institutional investors. Comparatively, 0.0% of Proteome Sciences shares are held by institutional investors. 29.0% of genedrive shares are held by insiders. Comparatively, 36.7% of Proteome Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Proteome Sciences has a net margin of -81.50% compared to genedrive's net margin of -500.75%. Proteome Sciences' return on equity of 33.80% beat genedrive's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
genedrive	-500.75%	-1,044.57%	-74.09%
Proteome Sciences	-81.50%	33.80%	-19.25%

Summary

genedrive beats Proteome Sciences on 7 of the 13 factors compared between the two stocks.

Get genedrive News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

GDR vs. The Competition

Export

Metric	genedrive	Life Sciences Tools & Services Industry	Healthcare Sector	LON Exchange
Market Cap	£18.46M	£9.22B	£6.93B	£2.87B
Dividend Yield	1.57%	1.47%	2.60%	6.13%
P/E Ratio	-1.45	62.26	281.16	369.49
Price / Sales	19.88	260.94	577.53	83,955.53
Price / Cash	2.00	25.96	71.79	27.89
Price / Book	0.41	38.11	12.86	7.07
Net Income	-£21.22M	£57.47B	£3.49B	£5.89B
7 Day Performance	6.98%	1.32%	2.64%	1.18%
1 Month Performance	-8.00%	-2.33%	-2.64%	0.90%
1 Year Performance	-0.86%	19.15%	76.00%	75.31%

genedrive Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GDR genedrive	N/A	GBX 1.15 flat	N/A	+0.6%	£18.46M	£929K	N/A	43	News Coverage Gap Up
ABDX Abingdon Health	N/A	GBX 9.50 -2.6%	N/A	+61.4%	£24.48M	£9.57M	N/A	84	Gap Down
YGEN Yourgene Health	N/A	N/A	N/A	N/A	£16.43M	£29.67M	N/A	253
VRCI Verici Dx	N/A	GBX 0.30 -14.3%	N/A	-56.4%	£8.96M	£3.66M	N/A	19	Negative News Gap Up
AGL ANGLE	N/A	GBX 2.35 -11.3%	N/A	-59.8%	£7.58M	£2.62M	N/A	650	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:GDR) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, VRCI, AGL, and PRM

How does genedrive compare to Abingdon Health?

Summary

How does genedrive compare to Yourgene Health?

Summary

How does genedrive compare to Verici Dx?

Summary

How does genedrive compare to ANGLE?

Summary

How does genedrive compare to Proteome Sciences?

Summary

New MarketBeat Followers Over Time

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

genedrive (GDR) Competitors

GDR vs. ABDX, YGEN, VRCI, AGL, and PRM

How does genedrive compare to Abingdon Health?

Does the media refer more to GDR or ABDX?

Is GDR or ABDX more profitable?

Which has more volatility & risk, GDR or ABDX?

Do institutionals and insiders believe in GDR or ABDX?

Which has better earnings and valuation, GDR or ABDX?

Summary

How does genedrive compare to Yourgene Health?

Does the media prefer GDR or YGEN?

Do insiders & institutionals have more ownership in GDR or YGEN?

Is GDR or YGEN more profitable?

Which has more risk & volatility, GDR or YGEN?

Which has better earnings and valuation, GDR or YGEN?

Summary

How does genedrive compare to Verici Dx?

Do insiders and institutionals have more ownership in VRCI or GDR?

Is VRCI or GDR more profitable?

Which has stronger earnings and valuation, VRCI or GDR?

Does the media favor VRCI or GDR?

Which has more volatility & risk, VRCI or GDR?

Summary

How does genedrive compare to ANGLE?

Does the media refer more to GDR or AGL?

Do institutionals & insiders hold more shares of GDR or AGL?

Which has preferable valuation & earnings, GDR or AGL?

Which has more risk and volatility, GDR or AGL?

Is GDR or AGL more profitable?

Summary

How does genedrive compare to Proteome Sciences?

Which has more volatility & risk, GDR or PRM?

Which has higher earnings & valuation, GDR or PRM?

Does the media prefer GDR or PRM?

Do insiders and institutionals hold more shares of GDR or PRM?

Is GDR or PRM more profitable?

Summary

New MarketBeat Followers Over Time

GDR vs. The Competition

genedrive Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools